Leveraging AAV gene therapy for safe durable expression of cytokine immunotherapies
Founded 2020
Partnered 2021
Nicole Paulk
Vasudev Bailey
Combining the promise of two transformative therapeutic technologies, AAV gene therapy and cytokine immunotherapy, into a single, powerful new treatment modality to fight cancer